Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized-Controlled Study of Cord Blood Consolidation Therapy for Intermediate- and High-Risk Elderly Acute Myeloid Leukemia

NCT07761702 is registered in ClinicalTrials.gov with Shanghai Jiao Tong University School of Medicine as lead sponsor.

NCT NCT07761702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07761702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized-Controlled Study of Cord Blood Consolidation Therapy for Intermediate- and High-Risk Elderly Acute Myeloid Leukemia
Lead sponsor
Shanghai Jiao Tong University School of Medicine
Phase
Phase 3
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
December 31, 2029
Enrollment
132 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aml (acute myelogenous leukemia)